UPDATE: Roth Capital Upgrades Inovio Pharmaceuticals (INO) to Neutral
Tweet Send to a Friend
(Updated - November 10, 2020 6:12 AM EST)
(updating comment)Roth Capital analyst Jonathan Aschoff upgraded Inovio Pharmaceuticals (NASDAQ: INO) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Roth Capital analyst Jonathan Aschoff upgraded Inovio Pharmaceuticals (NASDAQ: INO) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
